Connections PCL, Inc.

A241820

KR7241820000

Biotechnology & Medical Research

End-of-day quote Korea S.E. 21/03/2025			5-day change	1st Jan Change
6,040.00 ^KRW	-1.63%		-.--%	-

30/12/24	Yeom Ju-hwan agreed to acquire 36.90% stake in mCureX Therapeutics, Inc. from PCL, Inc. for KRW 13.0 billion.	CI
30/08/24	PCL, Inc. announced that it has received KRW 4.004999835 billion in funding	CI

4

Listed companies

1

Private companies

15

Insiders

Relation chart of related listed companies: PCL, Inc.

Active Relations

Past Relations

Related listed companies: PCL, Inc.

HLB PEP CO., LTD.

Sung-Yoon Hwang

BIOINFRA LIFE SCIENCE INC.

Active Relations

Past Relations

Relationship chart for related private companies: PCL, Inc.

Active Relations

Past Relations

Related private companies: PCL, Inc.

Dongguk University

Other Consumer Services

So-Yeon Kim

Seung-Ki Hong

Active Relations

Past Relations

Connection statistics

Active

Inactive

Listed companies

Private companies

Activities of related companies

Medical Specialties	2
Other Consumer Services	1
Real Estate Development	1
Pharmaceuticals: Major	1

Countries of related companies

South Korea

PCL Inc is a Korea-based company principally engaged in development and manufacture of vitro diagnostic medical device for immunological diagnosis. The Companyâ€™s products include blood bank screening products and quick diagnostic products. And the Company also provides platform services.

Employees

Sector

Biotechnology & Medical Research

More about the company